BG62167B1 - Производни на аскорбинова киселина,методи за тяхното получаване и приложение - Google Patents

Производни на аскорбинова киселина,методи за тяхното получаване и приложение Download PDF

Info

Publication number
BG62167B1
BG62167B1 BG98438A BG9843894A BG62167B1 BG 62167 B1 BG62167 B1 BG 62167B1 BG 98438 A BG98438 A BG 98438A BG 9843894 A BG9843894 A BG 9843894A BG 62167 B1 BG62167 B1 BG 62167B1
Authority
BG
Bulgaria
Prior art keywords
group
ascorbic acid
general formula
formula
compounds
Prior art date
Application number
BG98438A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG98438A (bg
Inventor
Bozidar Suskovic
Vanja Vela
Mira Buncic
Original Assignee
Pliva Farmaceutska,Kemijska,Prehrambena Ikozmeticka Industrija, Dionicko Drustvo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Farmaceutska,Kemijska,Prehrambena Ikozmeticka Industrija, Dionicko Drustvo filed Critical Pliva Farmaceutska,Kemijska,Prehrambena Ikozmeticka Industrija, Dionicko Drustvo
Publication of BG98438A publication Critical patent/BG98438A/bg
Publication of BG62167B1 publication Critical patent/BG62167B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/62—Three oxygen atoms, e.g. ascorbic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/66—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Furan Compounds (AREA)
BG98438A 1993-02-05 1994-02-04 Производни на аскорбинова киселина,методи за тяхното получаване и приложение BG62167B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HR930131A HRP930131A2 (en) 1993-02-05 1993-02-05 Amino-ascorbic acid derivatives, process for the preparation and use thereof
JP6013667A JPH07101950A (ja) 1993-02-05 1994-02-07 アミノ−アスコルビン酸誘導体、その製造法及び用途

Publications (2)

Publication Number Publication Date
BG98438A BG98438A (bg) 1994-09-30
BG62167B1 true BG62167B1 (bg) 1999-04-30

Family

ID=26316867

Family Applications (1)

Application Number Title Priority Date Filing Date
BG98438A BG62167B1 (bg) 1993-02-05 1994-02-04 Производни на аскорбинова киселина,методи за тяхното получаване и приложение

Country Status (11)

Country Link
EP (3) EP0609899A1 (fr)
JP (1) JPH07101950A (fr)
CN (1) CN1099753A (fr)
BG (1) BG62167B1 (fr)
CA (1) CA2114970C (fr)
CZ (1) CZ24594A3 (fr)
HR (1) HRP930131A2 (fr)
HU (1) HUT71606A (fr)
PL (1) PL302144A1 (fr)
SI (1) SI9400061A (fr)
SK (1) SK12894A3 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7763994B2 (en) 2005-01-25 2010-07-27 Panasonic Corporation Power source system
KR101119027B1 (ko) * 2009-05-07 2012-03-14 (주)코스몰 아스코르빈산 유도체의 제조방법
JP2013230984A (ja) * 2010-08-19 2013-11-14 Seiwa Kasei Co Ltd アスコルビン酸由来組成物、その製造方法、及び化粧料
EP3383924B1 (fr) * 2015-12-03 2021-04-14 3M Innovative Properties Company Composition polymérisable redox avec agents réducteurs photolabiles
CN118480032A (zh) * 2021-04-30 2024-08-13 禾美生物科技(浙江)有限公司 抗坏血酸多肽衍生物及其制备方法和应用
CN114369075B (zh) * 2022-02-14 2023-09-29 河北乐开节能科技股份有限公司 利用2-酮基-l-古龙酸的水溶液一步制备vc结晶的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2616351A1 (de) * 1975-05-03 1976-11-11 Hoffmann La Roche Halogenderivate
US4440738A (en) * 1982-06-10 1984-04-03 Mallinckrodt, Inc. Stable radiographic imaging agents
US4504462A (en) * 1982-06-10 1985-03-12 Mallinckrodt, Inc. Process for making a lyophilized product for use in skeletal imaging
EP0446539A1 (fr) * 1990-03-16 1991-09-18 Merrell Dow Pharmaceuticals Inc. Dérivé de l'acide ascorbique

Also Published As

Publication number Publication date
CA2114970A1 (fr) 1994-08-06
JPH07101950A (ja) 1995-04-18
EP0609899A1 (fr) 1994-08-10
HRP930131A2 (en) 1997-02-28
HUT71606A (en) 1996-01-29
SK12894A3 (en) 1994-12-07
PL302144A1 (en) 1994-08-08
BG98438A (bg) 1994-09-30
CA2114970C (fr) 1999-06-22
CZ24594A3 (en) 1994-08-17
SI9400061A (en) 1994-09-30
CN1099753A (zh) 1995-03-08
EP0791587A1 (fr) 1997-08-27
EP0791588A1 (fr) 1997-08-27
HU9400325D0 (en) 1994-05-30

Similar Documents

Publication Publication Date Title
Gibson et al. Selective removal of an N-BOC protecting group in the presence of a tert-butyl ester and other acid-sensitive groups
Nishizawa et al. Synthesis and structure-activity relations of bestatin analogs, inhibitors of aminopeptidase B
Greenberg et al. Structure and dynamics of Troeger's base and simple derivatives in acidic media
EP0227355A2 (fr) Prodrogue de rapamycine
BG60999B1 (en) Method for the preparation of clavulanic acid
Khomutov et al. Synthesis of hydroxylamine analogues of polyamines
Georg et al. Asymmetric synthesis of α-alkylated α-amino acids via Schmidt rearrangement of α, α-bisalkylated β-keto esters
BG62167B1 (bg) Производни на аскорбинова киселина,методи за тяхното получаване и приложение
Adamson et al. Simple and convenient synthesis of tert-butyl ethers of Fmoc-serine, Fmoc-threonine, and Fmoc-tyrosine
Iyengar et al. Preparation and antitumor activity of 7-substituted 1, 2-aziridinomitosenes
Sauer et al. Memory effect of chirality in the photocyclization of modified dipeptides
EP0081726B1 (fr) Dérivés amidiques de l'acide nitrobenzoique
Granier et al. First unequivocal synthesis of 1 or 8-N-monosubstituted 1, 4, 8, 12-tetraazacyclopentadecane
Wagenaar et al. Methodology for the preparation of N-guanidino-modified arginines and related derivatives
Fikes et al. Preassociating. alpha.-nucleophiles
US5610181A (en) Derivatives of amino-ascorbic acid, the processes for their preparation and use
RU2126398C1 (ru) Производные аминоаскорбиновой кислоты, способы их получения и производные галоидаскорбиновой кислоты
Wadher et al. Synthesis and biological evaluation of Schiff bases of Cinchophen as antimicrobial agents
DK161833B (da) Analogifremgangsmaade til fremstilling af n-(vinblastinoyl-23)-derivater af aminosyrer eller farmaceutisk acceptable syreadditionssalte deraf
Rosowsky et al. Analogs of methotrexate and aminopterin with. gamma.-methylene and. gamma.-cyano substitution of the glutamate side chain: synthesis and in vitro biological activity. 40
CN105566447A (zh) 一种凋亡抑制蛋白的类肽拮抗剂及其合成方法与应用
BG62520B1 (bg) Аналози на аргинина, притежаващи инхибираща активност върхуno-синтетазата
Thanassi Reaction of diaminomaleonitrile with acetaldehyde
CN109928916A (zh) 一类作为ido抑制剂的喹啉-4-基环己烷类化合物
CN118005716B (zh) 一种细胞毒素衍生物及制备方法与应用